Botulinum Toxin A (Botox )
Botulinum Toxin A (Botox ) is a pharmaceutical drug with 8 clinical trials. Currently 2 active trials ongoing. Historical success rate of 80.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
2
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
80.0%
4 of 5 finished
20.0%
1 ended early
2
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Comparative Evaluation of Preoperative Preparation Methods in Patients With Large Incisional Hernias
Ultrasonographic Evaluation of Masseter Muscle Changes After Botulinum Toxin Injection in Bruxism Patients
Effectiveness of Methods for Pyloric Drainage in esophagecTomY: Botox vs. Pyloromyotomy
Efficiency of Botulinum Toxin type-a in the Management of the Myofascial Pain
Intra-rectal Botulinum Toxin Injection for Intractable Non-retentive Fecal Incontinence in Children - an Open Label Pilot Study
Clinical Trials (8)
Comparative Evaluation of Preoperative Preparation Methods in Patients With Large Incisional Hernias
Ultrasonographic Evaluation of Masseter Muscle Changes After Botulinum Toxin Injection in Bruxism Patients
Effectiveness of Methods for Pyloric Drainage in esophagecTomY: Botox vs. Pyloromyotomy
Efficiency of Botulinum Toxin type-a in the Management of the Myofascial Pain
Intra-rectal Botulinum Toxin Injection for Intractable Non-retentive Fecal Incontinence in Children - an Open Label Pilot Study
Biofeedback Therapy Versus Botox Injection in Treatment of Dyssynergic Defecation.
Efficacy and Safety of Botulinum Toxin A for the Treatment of Refractory Overactive Bladder.
Botox as a Treatment for Chronic Male Pelvic Pain Syndrome
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8